September 21, 2023 at 07:54PM Biomarker-driven Drug Development for Allergic Diseases and Asthma; Public Workshop - 02/22/2024

This public workshop is intended to be a forum for the exchange of information and perspectives among regulators and academic investigators on the use of biomarkers to monitor, predict efficacy, and evaluate responses to novel therapeutics for allergic diseases.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/I5R6Y7n